The global market for Chemotherapy-Induced Nausea and Vomiting (CINV) was valued at US$ 2684 million in the year 2024 and is projected to reach a revised size of US$ 3183 million by 2031, growing at a CAGR of 2.5% during the forecast period.

Chemotherapy-Induced Nausea and Vomiting (CINV) Market

Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.

The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.

This report aims to provide a comprehensive presentation of the global market for Chemotherapy-Induced Nausea and Vomiting (CINV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy-Induced Nausea and Vomiting (CINV).

The Chemotherapy-Induced Nausea and Vomiting (CINV) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotherapy-Induced Nausea and Vomiting (CINV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chemotherapy-Induced Nausea and Vomiting (CINV) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report

Report Metric	Details
Report Name	Chemotherapy-Induced Nausea and Vomiting (CINV) Market
Accounted market size in year	US$ 2684 million
Forecasted market size in 2031	US$ 3183 million
CAGR	2.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CINV PONV
Segment by Application	Hospitals Ambulatory Surgical Centers Diagnostic Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Eisai, ProStrakan, Helsinn Holding, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting (CINV) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chemotherapy-Induced Nausea and Vomiting (CINV) Market growing?

Ans: The Chemotherapy-Induced Nausea and Vomiting (CINV) Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market size in 2031?

Ans: The Chemotherapy-Induced Nausea and Vomiting (CINV) Market size in 2031 will be US$ 3183 million.

Who are the main players in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

Ans: The main players in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market are Merck, Eisai, ProStrakan, Helsinn Holding, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro

What are the Application segmentation covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

Ans: The Applications covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Centers

What are the Type segmentation covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

Ans: The Types covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report are CINV, PONV

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CINV

1.2.3 PONV

1.3 Market by Application

1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2020-2031)

2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Region

2.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Region (2020-2025)

2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2026-2031)

2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Dynamics

2.3.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Trends

2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers

2.3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges

2.3.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue

3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2020-2025)

3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2020-2025)

3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue

3.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio

3.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2024

3.5 Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV) Head office and Area Served

3.6 Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Product and Application

3.7 Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Type

4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2020-2025)

4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2026-2031)

5 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Application

5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Application (2020-2025)

5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2020-2031)

6.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025)

6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2020-2031)

7.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025)

7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2020-2031)

8.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2020-2025)

8.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2020-2031)

9.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025)

9.4 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2020-2031)

10.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025)

10.4 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Eisai

11.2.1 Eisai Company Details

11.2.2 Eisai Business Overview

11.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.2.5 Eisai Recent Development

11.3 ProStrakan

11.3.1 ProStrakan Company Details

11.3.2 ProStrakan Business Overview

11.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.3.5 ProStrakan Recent Development

11.4 Helsinn Holding

11.4.1 Helsinn Holding Company Details

11.4.2 Helsinn Holding Business Overview

11.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.4.5 Helsinn Holding Recent Development

11.5 Mundipharma

11.5.1 Mundipharma Company Details

11.5.2 Mundipharma Business Overview

11.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.5.5 Mundipharma Recent Development

11.6 Qilu Pharma

11.6.1 Qilu Pharma Company Details

11.6.2 Qilu Pharma Business Overview

11.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.6.5 Qilu Pharma Recent Development

11.7 Teva

11.7.1 Teva Company Details

11.7.2 Teva Business Overview

11.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.7.5 Teva Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Heron Therapeutics

11.9.1 Heron Therapeutics Company Details

11.9.2 Heron Therapeutics Business Overview

11.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.9.5 Heron Therapeutics Recent Development

11.10 Roche

11.10.1 Roche Company Details

11.10.2 Roche Business Overview

11.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.10.5 Roche Recent Development

11.11 Mylan

11.11.1 Mylan Company Details

11.11.2 Mylan Business Overview

11.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.11.5 Mylan Recent Development

11.12 Tesaro

11.12.1 Tesaro Company Details

11.12.2 Tesaro Business Overview

11.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction

11.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

11.12.5 Tesaro Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CINV

Table 3. Key Players of PONV

Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2020-2025)

Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2026-2031)

Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends

Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers

Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges

Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints

Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players (2020-2025)

Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2024)

Table 17. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Headquarters and Area Served

Table 20. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Product and Application

Table 21. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2020-2025)

Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2026-2031)

Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2020-2025)

Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2026-2031)

Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 49. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Eisai Company Details

Table 52. Eisai Business Overview

Table 53. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 54. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 55. Eisai Recent Development

Table 56. ProStrakan Company Details

Table 57. ProStrakan Business Overview

Table 58. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 59. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 60. ProStrakan Recent Development

Table 61. Helsinn Holding Company Details

Table 62. Helsinn Holding Business Overview

Table 63. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 64. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 65. Helsinn Holding Recent Development

Table 66. Mundipharma Company Details

Table 67. Mundipharma Business Overview

Table 68. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 69. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 70. Mundipharma Recent Development

Table 71. Qilu Pharma Company Details

Table 72. Qilu Pharma Business Overview

Table 73. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 74. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 75. Qilu Pharma Recent Development

Table 76. Teva Company Details

Table 77. Teva Business Overview

Table 78. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 79. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 80. Teva Recent Development

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 84. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Heron Therapeutics Company Details

Table 87. Heron Therapeutics Business Overview

Table 88. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 89. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 90. Heron Therapeutics Recent Development

Table 91. Roche Company Details

Table 92. Roche Business Overview

Table 93. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 94. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 95. Roche Recent Development

Table 96. Mylan Company Details

Table 97. Mylan Business Overview

Table 98. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 99. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 100. Mylan Recent Development

Table 101. Tesaro Company Details

Table 102. Tesaro Business Overview

Table 103. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product

Table 104. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025) & (US$ Million)

Table 105. Tesaro Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Picture

Figure 2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2024 VS 2031

Figure 4. CINV Features

Figure 5. PONV Features

Figure 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Ambulatory Surgical Centers Case Studies

Figure 10. Diagnostic Centers Case Studies

Figure 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered

Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region: 2024 VS 2031

Figure 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2024

Figure 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2024

Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2020-2031)

Figure 20. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2020-2031)

Figure 24. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2020-2031)

Figure 32. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2020-2031)

Figure 40. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2020-2031)

Figure 44. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 48. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 49. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 50. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 51. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 52. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 53. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 55. Heron Therapeutics Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 56. Roche Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 57. Mylan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 58. Tesaro Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-6M14204

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Research Report 2025

FEATURED COMPANIES

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size

Chemotherapy-Induced Nausea and Vomiting (CINV) Market

Scope of Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report

Chapter Outline

FAQ for this report

How fast is Chemotherapy-Induced Nausea and Vomiting (CINV) Market growing?

What is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market size in 2031?

Who are the main players in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

What are the Application segmentation covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

What are the Type segmentation covered in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market report?

FEATURED COMPANIES

RELATED REPORTS